News | August 12, 2023
Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The inspection closed with zero observations and a classification of No Action Indicated
The company has reported total income of Rs. 310.07 crores during the period ended June 30, 2023
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
Subscribe To Our Newsletter & Stay Updated
